SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-24-000303
Filing Date
2024-03-22
Accepted
2024-03-22 16:59:51
Documents
2
Group Members
ORBIMED CAPITAL GP V LLCORBIMED CAPITAL LLCORBIMED GENESIS GP LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 ss3178815_sc13da.htm SC 13D/A 120103
2 JOINT FILING AGREEMENT ss3178815_ex9901.htm EX-99.1 7306
  Complete submission text file 0000947871-24-000303.txt   129164
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Subject) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90878 | Film No.: 24776041
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)